Cargando…
Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo’s cardiomyopathy
Takotsubo cardiomyopathy (TC) is a rare but increasingly recognized phenomenon, which can occur as a side effect of cancer treatment. We report an interesting case of a 53-year-old woman with non-small-cell lung cancer, who developed TC after chemotherapy with ibrutinib. Echocardiography revealed ma...
Autores principales: | Giza, Dana Elena, Moudgil, Rohit, Lopez-Mattei, Juan, Kim, Peter, Iliescu, Cezar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177044/ https://www.ncbi.nlm.nih.gov/pubmed/31020065 http://dx.doi.org/10.1093/ehjcr/ytx006 |
Ejemplares similares
-
Mid-ventricular Obstructive Cardiomyopathy after Takotsubo Cardiomyopathy
por: Tabira, Akihisa, et al.
Publicado: (2022) -
Stress Cardiomyopathy (Takotsubo Cardiomyopathy)
por: Khouri, Samer, et al.
Publicado: (2009) -
Ibrutinib-induced cardiomyopathy
por: Kyi, Htay Htay, et al.
Publicado: (2019) -
Takotsubo Cardiomyopathy
por: Schwab, Katerina
Publicado: (2022) -
Forme Fruste in Recurring Mid-Ventricular Variant of Takotsubo Cardiomyopathy
por: Piranavan, Paramarajan, et al.
Publicado: (2019)